_id

69105d33ccc777a4e85d58a6

Ticker

DSGN

Name

Design Therapeutics Inc

Exchange

NASDAQ

Address

6005 Hidden Valley Road, Carlsbad, CA, United States, 92011

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.designtx.com

Description

Design Therapeutics, Inc. a clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion. Its lead product candidates for potentially disease-modifying treatment comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function that brings to neurological, cardiac, and metabolic dysfunction; Myotonic Dystrophy Type-1, a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs; Fuchs Endothelial Corneal Dystrophy, a genetic eye disease characterized by bilateral degeneration of corneal endothelial cells and progressive loss of vision; and Huntington's Disease, a dominantly inherited, monogenic neurodegenerative disease characterized by movement, cognitive, and psychiatric disorders. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California.

Last Close

9.24

Volume

124013

Current Price

9.43

Change

2.0562770562770507

Last Updated

2025-11-29T12:23:58.080Z

Image

data:image/webp;base64,UklGRkwMAABXRUJQVlA4WAoAAAAQAAAAPwAAPwAAQUxQSN8IAAABmTM0RPQ/xGT12f9ZsaSefd/3Xmaf6WX2md5nX//vfZ9eZp/pffZ931dRQB3+g4+qUic4ctQtiyOoi6xWJ7iy1xFc5aeq1AmO4O6VOILqkrQDiZxWBDUEdcv9giOovhJ3gsPiCA55SxEkx/VIHEE1EklQXbJanaAGW+4E1eSoeyWO4K5lFMEhaxTBDYmYgAm4KAA8wTXe5Ke+48Uu8XR/U/iBF7qUxELHf/irP/iNn/mJ6O9B73+HJ3kKUJZ9POlxsFxCKBX+iNUXm/iLtzn+DH/ybT/0PBfzcTEKUG2xl3qZymVeqf9sT6T8zq8oeoBM3uCNYnCJz/ECAFSAaCGx+UtUXuE1Us/1ZFQeu1jmnur1Gr8lsD9W6fPf9RXfIrkJCCEgIASElxXJl+/G4wbn8wV+rqow4y69Vgn4OtflVmadtW8KUBCAEBAAJDH4NZl15w2G7Ov0leovlJm5ygGP3JdEWf/p1Jwbf9muUgOloAAFbYoD4/csfkSs2frxl+sG1c6Cibfwy3Q19Ge1vNP/avGnObPLyhSUglKABpqDXuFOdyuHa0FTZaU/MWbE5T3Li7gTn8UPLVi7TfDg5JUsubUclm03m42LgaNvMsVtvTuElzOpCV90CzeAu9xLSyvn1m3RWy0PbGJaD6kRQ2ola76dOawbxxUDO2UCAMrqPYaekycNE3eesAAFBEfQIhX5MQB20IuyrUaqEezVFZ0kzHLNMDQm9vhnutqN+u3JkFBQUNBSO+0WZoEBACy2m7HIifWVqtWs6DKTLcFS+jZhgFDgCwqnj9vNao0ABISotogh3o+X0mJPBPB9rpl01E/5Ni/ogmpsstJYbAMUgLjWNyUWbIwQgIBwnC/fjWdTkZxRNAP2exgD3a2sP7qb00XZaL7XB8SMu78EAJwzIE43BjlKAIAKi45xzPn66ymnW16IgLFKWqmUhY26dMA3RK/3WIQNfZUA4CiemUar7CYLDUpop2CU1bknezoolK0USnTMOrOVfHRNF2vB5j931ha+2T6kq1Rucq8busui17iZiKRexeOjIRewSDj8qVJ1Q9TBaw0Mz11r5NtZE+NO39c8Ol8G2EHh1FQ1ZM96WpvnKXL7FufIZE94eU2EQvmftfJmK/4haXELbE8NywFAxUXZ11/3gC+PQV28qWGIlQuaKICdPclwcLmUIS8E7BleZQCIbitB/4m21NsHyov4SWd+cV6TxsCt6igdf4f2LPpAjQOzdOpyHIycCWsOsmgrmUqu/ZwuyDwQbj+0oiLTiYBp7/mk8+wR3/HawUtDU78ZFRVdINicaiDX669Ls80ZEwRgN8VUNgLjApgpFacqm6u6EEN/GMZO79x9ltzmgomli1D8rZztxSkgwMcPanAtdFAfvooxwEat5qPj2XzIypTitcw9lXI9DG/Oc5RGuaBNNRyagE5nwDoax0blHaYQptJoVN1vgjV7/EGpM9Uivd1hAuicKXuS9dAj7yEMikxhxvbjgtjkEZ5HIunQBS2O0x6gs2ksAv9eO30dVVYYk2fxEbGbE0BrYgh2LlAN6+sysFFPmABQbzrNhsF4zt5YJ4FqAkgHI61yYaZhpVHAomNkAYCbj8OCxFx4NsrGci4jkJ440q7oeIlqao+nF6oVLB2l6mUpxhzkVCOWc/WASXCerkZzLAD3PGm8lZFA47n49ufUoEcllSK5shGY5B0+V1RWAEyo/SanuliazE6Ku3t5fUAgsRgVAEoJIYRSQOWKzXoUGrPxGVZ3InqJUUEgAAihoJQAUIpDC5QwANWTspln06ZPH0mw9rAKQJVYKKwEAGPOF3dMzYDHaVPYwwAHfU5YBGZuAG5OgZ3FUrsX73bfzjab8rTN2FsbQZ9Dm4zxzAJgWJvRmaJBWQTe7z/GHV8kT2E+YU7qpT3hYZZ9AFrJoqwQDTjTWT/mbDvcZmzcP69BryVHEy5vEEDQIpTd0GwNTUZbV5hQ8J/Wm0O//bZL6MkAhhYpXPZpEctV+k6ZInY+ozWBfofOSW4DQ4Az2KnRO9GCZmJ2lSMEzpsN0K+762O9Z9IADHkRvWZQi1RypEXkOvdl+I0oyxShwNHlXDg17QOIG7zYrM61dONtAvkUPuLDip1FiCkKqMcqdnbXmwbgcYxRGNe0HDW8WPzXbWr0H+43OztNZoDSg6w43iZBALb5UIiGOWg9UaHhT1nk+0OD5104cbrDkPSgp4xb3ckBIF3iBDmThFZfWyrfn+wOacb4yImrGcTCws6E/0FiDHSm/BzAQdaF2xScOriFz9t2Aua1/dLV/BckMVpeXixy1uPC4lROAhA73S/S7UFbm1rkO1UAGJfrxuNbW/mN0DK4rmcUMTcDdWvTA8D2TyIq9VkS2oWZHCZLwO/VSycfOqjeRrfW3FEyJIFdq6gCwFmTGYUNH3Tk3S2DrT4DgGK5nrja+3TTsW5MIAAhaq2lsk3jmM3s5XxdAO6G0yIrqx2TToJla72zugTFw8zZG426+WGMAgCJ1TgBwHjtNr0hljacSYoLHTt03vf+/zEaXeMBwCv6Il2HmwAUoEJ4LLp6xk61WHHGAFiOKmkRq7se6F7fvM6/5kphbYmk5uTkUGApoKE5MA/MfJFA41GlJcB4k0FyGfud1ujkimTeHgAN050OrZ2BTAkAkJiaHKbzbWj0n7PkeJx/1FDDMpsZ3n38kS6d7lIcqxx+VCZadAlYvlrKesJA4YGqBcsWHs00rrbVUGdlm9v+CfdOwKDkXG+0zVVWPHGbyhAMWldrl9nacgzdihmr+yUGLI5ut5sEypkMT8Co99Dazvr9/knoghSZB4WYppjE1Syt/HyiNqN29PZ6wghMr+7WTP71CneP1dKRIx0TiAYSU91Dy6TFUcC+ccZoJ2C+mA7Oa02XOr+YyVOKKdAoCGzRngsIwnhzf8FHRkkwP8yD5TDdd2S7jvwEqiatcmeREHno1T0fZs4vRMnWDnLFnsvnJlSDoMxkvinXJo5ITT9cu7azG/JOSsGhEChEubQWKMXZLMASMA8AVlA4IEYDAABwEACdASpAAEAAPrFInEmnJCKhMBYN+OAWCWwNuQQ5WP4u/TfyS9hOrf2v8Veuvlzjc9kv7rzuf472AeYBzgP6N6AP2V/ZX2Vf2k9wHoAdIB6AHlo/ux8Dv7r/uV7U3UAOIGUDDBMubslZyzfNiVd8uwtxLxHUVu4UQm4MoK8o95KZxD3l/8HwnI8gQAD+3OzRZx1C/OzCiOkvZAB+t6A3IE/3ZlIp/ENFmvHGEyz3YiPE8AGf/DX4H2by0PfdOiYhYXtYBkrpFbMXP/OY19mA5ICQCwDLCTQLAAcqPzX0moWi83u8hSe3EigM8EVqplKTCzg9cC9/vKKfsHaGkgoNeR5rwee0j8p4c1H63X4gqwRpTZRSBXb69c0XOKy1b/2v//tt//07j//ZCiCJopFWfG5v6XIGoJrLqBYt2BqCDP9tYTy7teRvmNT9XIM9z8ghQ0uNc4JMNxUFeReSyif8LrxP1iD34mDFrChd6UDX88ez9JuTWmnxPL2YDvKP/L9SqFtcpH0FeNhU86VWzhDZt1vYO3ExqiJyMTybpKHqcSVvLE6OXOBgMKTTqlfHZ0mOXmjJyShXC3q/H4jWwV9TEemuKfhIc6kI9fozQYu5BkUIJ4nkj9aCILT2mXYLAyKM9nOGXD4XwR6z/4Zz2l6Hb49qAW/2W+fIl3Tr873h6LnwNiaYG7cV+GdZ0kiv7GRzYanMZOP1Al5Hu+b8YZywtjFFqrn4F8pK2dCCKjtfN/+N2zC896fb7z+CJJ0VpUHNyWvootNXcrHdTF2qusZi8XcgH2SaXDTJgP9jZsGsZQ3uqyxbRV8iR03pnPYUswCq+HVl/GnThVHQWhxZEhYRLQbtWwPWPdBcBHOSpxfMWx60hbufi9BgmiE+Nc9JhCa/6jW+n7c3l5s/Pnq9Zp8jRmR+Z1cacX2J/A5c8PsuS+CGlj+/1+lLNkj+AuHUGq9vleiVf0DwTIeKq+XK14lkCohRsHx+odcW7Xqi48CB9WYGXN4DyJi5YFH7un7JTHQlDmd8M9A2ics/fM3PlAfm2dEPcYN17kcHVFlEpnOcjQnBf48R5R2SnNL5STxDImhDTD9LzPJPsfPn7E9acFAjzOsOvDAA

Ipo Date

2021-03-26T00:00:00.000Z

Market Cap

534889696

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.752

Sentiment Sources

4

Rating

3.3333

Target Price

10.6667

Strong Buy

0

Buy

1

Hold

2

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

14589000

Gross Profit

-14589000

Operating Expenses

4722000

Operating Income

-19311000

Interest Expense

-

Pretax Income

-16997000

Net Income

-16997000

Eps

-0.29844954958560077

Dividends Per Share

-

Shares Outstanding

56963757

Income Tax Expense

-

EBITDA

-16842000

Operating Margin

-

Total Other Income Expense Net

2314000

Cash

15088000

Short Term Investments

190882000

Receivables

1381000

Inventories

-

Total Current Assets

209029000

Property Plant Equipment

2741000

Total Assets

211770000

Payables

1913000

Short Term Debt

866000

Long Term Debt

-

Total Liabilities

12050000

Equity

199720000

Depreciation

155000

Change In Working Capital

2864000

Cash From Operations

-11162000

Capital Expenditures

0

Cash From Investing

6510000

Cash From Financing

37000

Net Change In Cash

-4615000

PE

-

PB

2.689004208742239

ROE

-8.510414580412577

ROA

-8.026160457099683

FCF

-11162000

Fcf Percent

-

Piotroski FScore

1

Health Score

43

Deep Value Investing Score

3

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

3.8

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

2.5

Net Net Investing Score

2.5

Quality Investing Score

2.5

Value Investing Score

4

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

14589000

Quarters > 0 > income Statement > gross Profit

-14589000

Quarters > 0 > income Statement > operating Expenses

4722000

Quarters > 0 > income Statement > operating Income

-19311000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-16997000

Quarters > 0 > income Statement > net Income

-16997000

Quarters > 0 > income Statement > eps

-0.29844954958560077

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

56950999

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-16842000

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

2314000

Quarters > 0 > balance Sheet > cash

15088000

Quarters > 0 > balance Sheet > short Term Investments

190882000

Quarters > 0 > balance Sheet > receivables

1381000

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

209029000

Quarters > 0 > balance Sheet > property Plant Equipment

2741000

Quarters > 0 > balance Sheet > total Assets

211770000

Quarters > 0 > balance Sheet > payables

1913000

Quarters > 0 > balance Sheet > short Term Debt

866000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

12050000

Quarters > 0 > balance Sheet > equity

199720000

Quarters > 0 > cash Flow > net Income

-16997000

Quarters > 0 > cash Flow > depreciation

155000

Quarters > 0 > cash Flow > change In Working Capital

2864000

Quarters > 0 > cash Flow > cash From Operations

-11162000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

6510000

Quarters > 0 > cash Flow > cash From Financing

37000

Quarters > 0 > cash Flow > net Change In Cash

-4615000

Quarters > 0 > ratios > PE

-0.29844954958560077

Quarters > 0 > ratios > PB

2.689004208742239

Quarters > 0 > ratios > ROE

-8.510414580412577

Quarters > 0 > ratios > ROA

-8.026160457099683

Quarters > 0 > ratios > FCF

-11162000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

43

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

152000

Quarters > 1 > income Statement > gross Profit

-152000

Quarters > 1 > income Statement > operating Expenses

21417000

Quarters > 1 > income Statement > operating Income

-21569000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-19083000

Quarters > 1 > income Statement > net Income

-19083000

Quarters > 1 > income Statement > eps

-0.33561740059530715

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

56859388

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-18931000

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

2486000

Quarters > 1 > balance Sheet > cash

19703000

Quarters > 1 > balance Sheet > short Term Investments

196573000

Quarters > 1 > balance Sheet > receivables

1348000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

219794000

Quarters > 1 > balance Sheet > property Plant Equipment

3092000

Quarters > 1 > balance Sheet > total Assets

222886000

Quarters > 1 > balance Sheet > payables

1013000

Quarters > 1 > balance Sheet > short Term Debt

844000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

9849000

Quarters > 1 > balance Sheet > equity

213037000

Quarters > 1 > cash Flow > net Income

-19083000

Quarters > 1 > cash Flow > depreciation

152000

Quarters > 1 > cash Flow > change In Working Capital

994000

Quarters > 1 > cash Flow > cash From Operations

-14441000

Quarters > 1 > cash Flow > capital Expenditures

87000

Quarters > 1 > cash Flow > cash From Investing

20116000

Quarters > 1 > cash Flow > cash From Financing

361000

Quarters > 1 > cash Flow > net Change In Cash

6036000

Quarters > 1 > ratios > PE

-0.33561740059530715

Quarters > 1 > ratios > PB

2.5168587092383015

Quarters > 1 > ratios > ROE

-8.95759891474251

Quarters > 1 > ratios > ROA

-8.56177597516219

Quarters > 1 > ratios > FCF

-14528000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

43

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

159000

Quarters > 2 > income Statement > gross Profit

-159000

Quarters > 2 > income Statement > operating Expenses

20418000

Quarters > 2 > income Statement > operating Income

-20418000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-17715000

Quarters > 2 > income Statement > net Income

-17715000

Quarters > 2 > income Statement > eps

-0.3121155431126706

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

56757827

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-20259000

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

2703000

Quarters > 2 > balance Sheet > cash

13667000

Quarters > 2 > balance Sheet > short Term Investments

216007000

Quarters > 2 > balance Sheet > receivables

1405000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

233644000

Quarters > 2 > balance Sheet > property Plant Equipment

3404000

Quarters > 2 > balance Sheet > total Assets

237475000

Quarters > 2 > balance Sheet > payables

3180000

Quarters > 2 > balance Sheet > short Term Debt

821000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

9556000

Quarters > 2 > balance Sheet > equity

227919000

Quarters > 2 > cash Flow > net Income

-17715000

Quarters > 2 > cash Flow > depreciation

159000

Quarters > 2 > cash Flow > change In Working Capital

-1708000

Quarters > 2 > cash Flow > cash From Operations

-16789000

Quarters > 2 > cash Flow > capital Expenditures

72000

Quarters > 2 > cash Flow > cash From Investing

7870000

Quarters > 2 > cash Flow > cash From Financing

23000

Quarters > 2 > cash Flow > net Change In Cash

-8896000

Quarters > 2 > ratios > PE

-0.3121155431126706

Quarters > 2 > ratios > PB

2.3483180805900337

Quarters > 2 > ratios > ROE

-7.772498124333644

Quarters > 2 > ratios > ROA

-7.45973260343194

Quarters > 2 > ratios > FCF

-16861000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

43

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

588000

Quarters > 3 > income Statement > cost Of Revenue

149000

Quarters > 3 > income Statement > gross Profit

294000

Quarters > 3 > income Statement > operating Expenses

16694000

Quarters > 3 > income Statement > operating Income

-16694000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-13651000

Quarters > 3 > income Statement > net Income

-13651000

Quarters > 3 > income Statement > eps

-0.24083508786043667

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

56681940

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-16545000

Quarters > 3 > income Statement > operating Margin

-2839.1156462585036

Quarters > 3 > income Statement > total Other Income Expense Net

3043000

Quarters > 3 > balance Sheet > cash

22563000

Quarters > 3 > balance Sheet > short Term Investments

222914000

Quarters > 3 > balance Sheet > receivables

1263000

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

248040000

Quarters > 3 > balance Sheet > property Plant Equipment

3626000

Quarters > 3 > balance Sheet > total Assets

252093000

Quarters > 3 > balance Sheet > payables

2186000

Quarters > 3 > balance Sheet > short Term Debt

800000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

9996000

Quarters > 3 > balance Sheet > equity

242097000

Quarters > 3 > cash Flow > net Income

-13651000

Quarters > 3 > cash Flow > depreciation

149000

Quarters > 3 > cash Flow > change In Working Capital

1612000

Quarters > 3 > cash Flow > cash From Operations

-9860000

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

1832000

Quarters > 3 > cash Flow > cash From Financing

263000

Quarters > 3 > cash Flow > net Change In Cash

-7765000

Quarters > 3 > ratios > PE

-0.24083508786043667

Quarters > 3 > ratios > PB

2.207836917433921

Quarters > 3 > ratios > ROE

-5.638648971280107

Quarters > 3 > ratios > ROA

-5.415065075190506

Quarters > 3 > ratios > FCF

-9860000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-16.768707482993197

Quarters > 3 > health Score

35

Valuation > metrics > PE

-0.29844954958560077

Valuation > metrics > PB

2.689004208742239

Valuation > final Score

80

Valuation > verdict

Fair

Profitability > metrics > ROE

-8.510414580412577

Profitability > metrics > ROA

-8.131407603729626

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.06033446825555778

Risk > metrics > Interest Coverage

-124.58709677419355

Risk > final Score

-438

Risk > verdict

High

Liquidity > metrics > Current Ratio

75.21734436847787

Liquidity > metrics > Quick Ratio

75.21734436847787

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

80

Prev Valuations > 1

80

Prev Valuations > 2

80

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

0

Prev Risks > 0

-508

Prev Risks > 1

28

Prev Risks > 2

37

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:24:14.203Z